Tag Archives: EHRs
By Casey McDonald | Published: December 12, 2014
Greetings to the Biotech/Pharma twittersphere! Starting this week, we’ll be compiling top tweets about the industry (semi-)regularly in this blog. Please help with suggestions on what you think should make the list. Tweet @PharmExecutive or email firstname.lastname@example.org.
By Ben Comer | Published: June 5, 2013
Dr. Richard Gliklich, president of Quintiles Outcome and a professor at Harvard Medical School, highlights the most prominent post-approval issues and risks coming out of this year’s Post-Approval Summit, held on May 7th-8th. Brand managers prodding products across the regulatory finish line to commercialization are finding themselves in yet another race, instead of in the […]
By Jill Wechsler | Published: April 30, 2013
The new National Patient-Centered Clinical Research Network funded by the Patient-Centered Outcomes Research Institute (PCORI) aims to provide patients and clinicians with useful information on treatment options and outcomes. By encouraging more comparative clinical effectiveness research (CER), the program also has potential to support development of new drugs and devices, explained PCORI executive director Joe […]
By Ben Comer | Published: September 12, 2012
Industry executives and government officials convened in Washington DC yesterday to examine the present state of health information technology (HIT), and to identify the bugs, challenges and hiccups that continue to plague EHR platforms, and the policies that regulate them.
By Ben Comer | Published: June 15, 2012
A diverse group of HIT professionals – including physicians, academics, developers and entrepreneurs – gathered at Sudler & Hennessey’s Health and Technology Summit in New York City to discuss the challenges related to health information technology implementation, and the ways to move forward.